In vivo Biodistribution and Clearance of Magnetic Iron Oxide Nanoparticles for Medical Applications

References

• Bao Y, Sherwood JA, Sun Z. Magnetic iron oxide nanoparticles as T 1 contrast agents for magnetic resonance imaging. J Mater Chem C. 2018;6(6):1280–1290. doi:10.1039/C7TC05854C
   Web of Science ®Google Scholar
• Huang J, Zhong X, Wang L, Yang L, Mao H. Improving the magnetic resonance imaging contrast and detection methods with engineered magnetic nanoparticles. Theranostics. 2012;2(1):86–102. doi:10.7150/thno.4006
   PubMed Web of Science ®Google Scholar
• Zhou Q, Wei Y. For better or worse, iron overload by superparamagnetic iron oxide nanoparticles as a MRI contrast agent for chronic liver diseases. Chem Res Toxicol. 2017;30(1):73–80. doi:10.1021/acs.chemrestox.6b00298
   PubMed Web of Science ®Google Scholar
• Russell E, Dunne V, Russell B, et al. Impact of superparamagnetic iron oxide nanoparticles on in vitro and in vivo radiosensitisation of cancer cells. Radiat Oncol. 2021;16(1):104. doi:10.1186/s13014-021-01829-y
   PubMed Web of Science ®Google Scholar
• Palzer J, Eckstein L, Slabu I, Reisen O, Neumann UP, Roeth AA. Iron oxide nanoparticle-based hyperthermia as a treatment option in various gastrointestinal malignancies. Nanomaterials. 2021;11(11):3013. doi:10.3390/nano11113013
   Web of Science ®Google Scholar
• Obaidat IM, Narayanaswamy V, Alaabed S, Sambasivam S, Muralee Gopi CVV. Principles of magnetic hyperthermia: a focus on using multifunctional hybrid magnetic nanoparticles. Magnetochemistry. 2019;5(4):67. doi:10.3390/magnetochemistry5040067
   Web of Science ®Google Scholar
• Mu X, Li J, Yan S, et al. siRNA Delivery with stem cell membrane-coated magnetic nanoparticles for imaging-guided photothermal therapy and gene therapy. ACS Biomater Sci Eng. 2018;4(11):3895–3905. doi:10.1021/acsbiomaterials.8b00858
   PubMed Web of Science ®Google Scholar
• Eivazzadeh-Keihan R, Bahreinizad H, Amiri Z, et al. Functionalized magnetic nanoparticles for the separation and purification of proteins and peptides. TrAC Trends Anal Chem. 2021;141:116291. doi:10.1016/j.trac.2021.116291
   Web of Science ®Google Scholar
• Uskoković V, Tang S, Wu VM. Targeted magnetic separation of biomolecules and cells using earthicle-based ferrofluids. Nanoscale. 2019;11(23):11236–11253. doi:10.1039/C9NR01579E
   PubMed Web of Science ®Google Scholar
• El-Boubbou K. Magnetic iron oxide nanoparticles as drug carriers: clinical relevance. Nanomed. 2018;13(8):953–971. doi:10.2217/nnm-2017-0336
   PubMed Web of Science ®Google Scholar
• Estelrich J, Escribano E, Queralt J, Busquets M. Iron oxide nanoparticles for magnetically-guided and magnetically-responsive drug delivery. Int J Mol Sci. 2015;16(12):8070–8101. doi:10.3390/ijms16048070
   PubMedGoogle Scholar
• Nowak-Jary J, Defort A, Kozioƚ JJ. Modified Physicochemical Properties of Acidic Model Drugs Immobilized on Fe3O4Magnetic Iron Oxide Nanoparticles. Pharm Chem J. 2020;53(11):1025–1035. doi:10.1007/s11094-020-02118-w
   Web of Science ®Google Scholar
• Kohler N, Sun C, Fichtenholtz A, Gunn J, Fang C, Zhang M. Methotrexate-Immobilized Poly(ethylene glycol) Magnetic Nanoparticles for MR Imaging and Drug Delivery. Small. 2006;2(6):785–792. doi:10.1002/smll.200600009
   PubMed Web of Science ®Google Scholar
• Nowak‐Jary J, Machnicka B, Kozioł JJ. Cytotoxicity of chlorambucil immobilized on magnetic iron oxide nanoparticles Fe 3 O 4. Micro Nano Lett. 2021;16(10):515–523. doi:10.1049/mna2.12080
   Web of Science ®Google Scholar
• Stanicki D, Vangijzegem T, Ternad I, Laurent S. An update on the applications and characteristics of magnetic iron oxide nanoparticles for drug delivery. Expert Opin Drug Deliv. 2022;19(3):321–335. doi:10.1080/17425247.2022.2047020
   PubMed Web of Science ®Google Scholar
• Foy SP, Manthe RL, Foy ST, Dimitrijevic S, Krishnamurthy N, Labhasetwar V. Optical imaging and magnetic field targeting of magnetic nanoparticles in tumors. ACS Nano. 2010;4(9):5217–5224. doi:10.1021/nn101427t
   PubMed Web of Science ®Google Scholar
• Huang X, Jain PK, El-Sayed IH, El-Sayed MA. Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy. Nanomed. 2007;2(5):681–693. doi:10.2217/17435889.2.5.681
   PubMed Web of Science ®Google Scholar
• Cheheltani R, Ezzibdeh RM, Chhour P, et al. Tunable, biodegradable gold nanoparticles as contrast agents for computed tomography and photoacoustic imaging. Biomaterials. 2016;102:87–97. doi:10.1016/j.biomaterials.2016.06.015
   PubMed Web of Science ®Google Scholar
• Retif P, Pinel S, Toussaint M, et al. Nanoparticles for Radiation Therapy Enhancement: the Key Parameters. Theranostics. 2015;5(9):1030–1044. doi:10.7150/thno.11642
   PubMed Web of Science ®Google Scholar
• Filippi L, Frantellizzi V, Chiaravalloti A, et al. Prognostic and theranostic applications of positron emission tomography for a personalized approach to metastatic castration-resistant prostate cancer. Int J Mol Sci. 2021;22(6):3036. doi:10.3390/ijms22063036
   PubMed Web of Science ®Google Scholar
• Daems N, Michiels C, Lucas S, Baatout S, Aerts A. Gold nanoparticles meet medical radionuclides. Nucl Med Biol. 2021;100-101:61–90. doi:10.1016/j.nucmedbio.2021.06.001
   PubMed Web of Science ®Google Scholar
• Pellico J, Gawne PJ, De Rosales TM. Radiolabelling of nanomaterials for medical imaging and therapy. Chem Soc Rev. 2021;50(5):3355–3423. doi:10.1039/D0CS00384K
   PubMed Web of Science ®Google Scholar
• Pérez-Medina C, Teunissen AJP, Kluza E, Mulder WJM, Van Der Meel R. Nuclear imaging approaches facilitating nanomedicine translation. Adv Drug Deliv Rev. 2020;154-155:123–141. doi:10.1016/j.addr.2020.07.017
   PubMed Web of Science ®Google Scholar
• Majkowska-Pilip A, Gawęda W, Żelechowska-Matysiak K, Wawrowicz K, Bilewicz A. Nanoparticles in Targeted Alpha Therapy. Nanomaterials. 2020;10(7):1366. doi:10.3390/nano10071366
   Web of Science ®Google Scholar
• Datta P, Ray S. Nanoparticulate formulations of radiopharmaceuticals: strategy to improve targeting and biodistribution properties. J Label Compd Radiopharm. 2020;63(7):333–355. doi:10.1002/jlcr.3839
   Web of Science ®Google Scholar
• Zhao J, Liu P, Ma J, et al. Enhancement of radiosensitization by silver nanoparticles functionalized with polyethylene glycol and aptamer As1411 for glioma irradiation therapy. Int J Nanomedicine. 2019;14:9483–9496. doi:10.2147/IJN.S224160
   PubMed Web of Science ®Google Scholar
• Chen YS, Hung YC, Liau I, Huang GS. Assessment of the in vivo toxicity of gold nanoparticles. Nanoscale Res Lett. 2009;4(8):858. doi:10.1007/s11671-009-9334-6
   PubMed Web of Science ®Google Scholar
• Cho WS, Cho M, Jeong J, et al. Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. Toxicol Appl Pharmacol. 2009;236(1):16–24. doi:10.1016/j.taap.2008.12.023
   PubMed Web of Science ®Google Scholar
• Begines B, Ortiz T, Pérez-Aranda M, et al. Polymeric nanoparticles for drug delivery: recent developments and future prospects. Nanomaterials. 2020;10(7):1403. doi:10.3390/nano10071403
   Web of Science ®Google Scholar
• Bose A, Roy Burman D, Sikdar B, Patra P. Nanomicelles: types, properties and applications in drug delivery. IET Nanobiotechnol. 2021;15(1):19–27. doi:10.1049/nbt2.12018
   PubMed Web of Science ®Google Scholar
• Kahraman E, Güngör S, Özsoy Y. Potential enhancement and targeting strategies of polymeric and lipid-based nanocarriers in dermal drug delivery. Ther Deliv. 2017;8(11):967–985. doi:10.4155/tde-2017-0075
   PubMed Web of Science ®Google Scholar
• Skotland T, Iversen TG, Sandvig K. New metal-based nanoparticles for intravenous use: requirements for clinical success with focus on medical imaging. Nanomedicine Nanotechnol Biol Med. 2010;6(6):730–737. doi:10.1016/j.nano.2010.05.002
   PubMed Web of Science ®Google Scholar
• Couto D, Freitas M, Costa VM, et al. Biodistribution of polyacrylic acid-coated iron oxide nanoparticles is associated with proinflammatory activation and liver toxicity: toxicity of iron oxide nanoparticles: an in vivo study. J Appl Toxicol. 2016;36(10):1321–1331. doi:10.1002/jat.3323
   PubMed Web of Science ®Google Scholar
• Aboushoushah S, Alshammari W, Darwesh R, Elbaily N. Toxicity and biodistribution assessment of curcumin-coated iron oxide nanoparticles: multidose administration. Life Sci. 2021;277:119625. doi:10.1016/j.lfs.2021.119625
   PubMed Web of Science ®Google Scholar
• Jain TK, Reddy MK, Morales MA, Leslie-Pelecky DL, Biodistribution LV. Clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats. Mol Pharm. 2008;5(2):316–327. doi:10.1021/mp7001285
   PubMed Web of Science ®Google Scholar
• Enteshari Najafabadi R, Kazemipour N, Esmaeili A, Beheshti S, Nazifi S. Using superparamagnetic iron oxide nanoparticles to enhance bioavailability of quercetin in the intact rat brain. BMC Pharmacol Toxicol. 2018;19(1):59. doi:10.1186/s40360-018-0249-7
   PubMedGoogle Scholar
• Ruiz A, Hernández Y, Cabal C, et al. Biodistribution and pharmacokinetics of uniform magnetite nanoparticles chemically modified with polyethylene glycol. Nanoscale. 2013;5(23):11400. doi:10.1039/c3nr01412f
   PubMed Web of Science ®Google Scholar
• Sun Z, Worden M, Thliveris JA, et al. Biodistribution of negatively charged iron oxide nanoparticles (IONPs) in mice and enhanced brain delivery using lysophosphatidic acid (LPA). Nanomedicine Nanotechnol Biol Med. 2016;12(7):1775–1784. doi:10.1016/j.nano.2016.04.008
   PubMed Web of Science ®Google Scholar
• Wang X, Zhang J, Yang X, et al. In vivo assessment of hepatotoxicity, nephrotoxicity and biodistribution using 3-aminopropyltriethoxysilane-coated magnetic nanoparticles (APTS-MNPs) in ICR mice. Chin Sci Bull. 2014;59(16):1800–1808. doi:10.1007/s11434-014-0296-4
   Google Scholar
• Zhao H, Gu W, Ye L, Yang H. Biodistribution of PAMAM dendrimer conjugated magnetic nanoparticles in mice. J Mater Sci Mater Med. 2014;25(3):769–776. doi:10.1007/s10856-013-5104-1
   PubMed Web of Science ®Google Scholar
• Katsnelson BA, Degtyareva TD, Minigalieva II, et al. Subchronic systemic toxicity and bioaccumulation of Fe 3 O 4 nano- and microparticles following repeated intraperitoneal administration to rats. Int J Toxicol. 2011;30(1):59–68. doi:10.1177/1091581810385149
   PubMed Web of Science ®Google Scholar
• Veiseh O, Gunn JW, Zhang M. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv Drug Deliv Rev. 2010;62(3):284–304. doi:10.1016/j.addr.2009.11.002
   PubMed Web of Science ®Google Scholar
• Arami H, Khandhar A, Liggitt D, Krishnan KM. In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles. Chem Soc Rev. 2015;44(23):8576–8607. doi:10.1039/C5CS00541H
   PubMed Web of Science ®Google Scholar
• Yang L, Kuang H, Zhang W, et al. Size dependent biodistribution and toxicokinetics of iron oxide magnetic nanoparticles in mice. Nanoscale. 2015;7(2):625–636. doi:10.1039/C4NR05061D
   PubMed Web of Science ®Google Scholar
• Kawai Y, Smedsrød B, Elvevold K, Wake K. Uptake of lithium carmine by sinusoidal endothelial and Kupffer cells of the rat liver: new insights into the classical vital staining and the reticulo-endothelial system. Cell Tissue Res. 1998;292(2):395–410. doi:10.1007/s004410051069
   PubMed Web of Science ®Google Scholar
• Singh I, Vasudeva N, Mishra S. Inderbir Singh’s Textbook of Human Histology: With Colour Atlas and Practical Guide. Jaypee, The Health Sciences Publishers; 2014.
   Google Scholar
• Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol. 2011;11(11):723–737. doi:10.1038/nri3073
   PubMed Web of Science ®Google Scholar
• Shi C, Pamer EG. Monocyte recruitment during infection and inflammation. Nat Rev Immunol. 2011;11(11):762–774. doi:10.1038/nri3070
   PubMed Web of Science ®Google Scholar
• Lee MJE, Veiseh O, Bhattarai N, et al. Rapid pharmacokinetic and biodistribution studies using cholorotoxin-conjugated iron oxide nanoparticles: a novel non-radioactive method. PLoS One. 2010;5(3):e9536. doi:10.1371/journal.pone.0009536
   PubMed Web of Science ®Google Scholar
• Levy M, Luciani N, Alloyeau D, et al. Long term in vivo biotransformation of iron oxide nanoparticles. Biomaterials. 2011;32(16):3988–3999. doi:10.1016/j.biomaterials.2011.02.031
   PubMed Web of Science ®Google Scholar
• Beckmann N, Cannet C, Babin AL, et al. In vivo visualization of macrophage infiltration and activity in inflammation using magnetic resonance imaging. WIREs Nanomed Nanobiotechnology. 2009;1(3):272–298. doi:10.1002/wnan.16
   Google Scholar
• Weissleder R, Bogdanov A, Neuwelt EA, Papisov M. Long-circulating iron oxides for MR imaging. Adv Drug Deliv Rev. 1995;16(2–3):321–334. doi:10.1016/0169-409X(95)00033-4
   Web of Science ®Google Scholar
• Vonarbourg A, Passirani C, Saulnier P, Benoit JP. Parameters influencing the stealthiness of colloidal drug delivery systems. Biomaterials. 2006;27(24):4356–4373. doi:10.1016/j.biomaterials.2006.03.039
   PubMed Web of Science ®Google Scholar
• Owensiii D, Peppas N. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm. 2006;307(1):93–102. doi:10.1016/j.ijpharm.2005.10.010
   PubMedGoogle Scholar
• Dixon LJ, Barnes M, Tang H, Pritchard MT, Nagy LE. Kupffer Cells in the Liver. In: Terjung R, editor. Comprehensive Physiology. 1st ed. Wiley; 2013:785–797. doi:10.1002/cphy.c120026
   Google Scholar
• Ross MH, Pawlina W. Histology: A Text and Atlas: With Correlated Cell and Molecular Biology. Wolters Kluwer Health; 2020.
   Google Scholar
• Gu L, Fang RH, Sailor MJ, Park JH. In vivo clearance and toxicity of monodisperse iron oxide nanocrystals. ACS Nano. 2012;6(6):4947–4954. doi:10.1021/nn300456z
   PubMed Web of Science ®Google Scholar
• Seested T, Appa RS, Christensen EI, et al. In vivo clearance and metabolism of recombinant activated factor VII (rFVIIa) and its complexes with plasma protease inhibitors in the liver. Thromb Res. 2011;127(4):356–362. doi:10.1016/j.thromres.2010.12.016
   PubMed Web of Science ®Google Scholar
• Lee CM, Jeong HJ, Kim SL, et al. SPION-loaded chitosan–linoleic acid nanoparticles to target hepatocytes. Int J Pharm. 2009;371(1–2):163–169. doi:10.1016/j.ijpharm.2008.12.021
   PubMed Web of Science ®Google Scholar
• Kim HR, Andrieux K, Delomenie C, et al. Analysis of plasma protein adsorption onto PEGylated nanoparticles by complementary methods: 2-DE, CE and Protein Lab-on-chip® system. ELECTROPHORESIS. 2007;28(13):2252–2261. doi:10.1002/elps.200600694
   PubMed Web of Science ®Google Scholar
• Tate JA, Petryk AA, Giustini AJ, Hoopes PJ. In Vivo Biodistribution of Iron Oxide Nanoparticles: An Overview. Energy Based Treat Tissue Assess. 2011;790117:384. doi:10.1117/12.876414
   Google Scholar
• Tietze R, Jurgons R, Lyer S, et al. Quantification of drug-loaded magnetic nanoparticles in rabbit liver and tumor after in vivo administration. J Magn Magn Mater. 2009;321(10):1465–1468. doi:10.1016/j.jmmm.2009.02.068
   Web of Science ®Google Scholar
• Shanehsazzadeh S, Oghabian MA, Daha FJ, Amanlou M, Allen BJ. Biodistribution of ultra small superparamagnetic iron oxide nanoparticles in BALB mice. J Radioanal Nucl Chem. 2013;295(2):1517–1523. doi:10.1007/s10967-012-2173-4
   Web of Science ®Google Scholar
• Wang H, Kumar R, Nagesha D, Duclos RI, Sridhar S, Gatley SJ. Integrity of 111In-radiolabeled superparamagnetic iron oxide nanoparticles in the mouse. Nucl Med Biol. 2015;42(1):65–70. doi:10.1016/j.nucmedbio.2014.08.014
   PubMed Web of Science ®Google Scholar
• Yazdani F, Fattahi B, Azizi N. Synthesis of functionalized magnetite nanoparticles to use as liver targeting MRI contrast agent. J Magn Magn Mater. 2016;406:207–211. doi:10.1016/j.jmmm.2016.01.026
   Web of Science ®Google Scholar
• Zhao Z, Zhou Z, Bao J, et al. Octapod iron oxide nanoparticles as high-performance T2 contrast agents for magnetic resonance imaging. Nat Commun. 2013;4(1):2266. doi:10.1038/ncomms3266
   PubMedGoogle Scholar
• Maeng JH, Lee DH, Jung KH, et al. Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer. Biomaterials. 2010;31(18):4995–5006. doi:10.1016/j.biomaterials.2010.02.068
   PubMed Web of Science ®Google Scholar
• Xu X, Zhou X, Xiao B, et al. Glutathione-responsive magnetic nanoparticles for highly sensitive diagnosis of liver metastases. Nano Lett. 2021;21(5):2199–2206. doi:10.1021/acs.nanolett.0c04967
   PubMed Web of Science ®Google Scholar
• Eftekhari A, Arjmand A, Asheghvatan A, et al. The potential application of magnetic nanoparticles for liver fibrosis theranostics. Front Chem. 2021;9:674786. doi:10.3389/fchem.2021.674786
   PubMed Web of Science ®Google Scholar
• Saraswathy A, Nazeer SS, Jeevan M, et al. Citrate coated iron oxide nanoparticles with enhanced relaxivity for in vivo magnetic resonance imaging of liver fibrosis. Colloids Surf B Biointerfaces. 2014;117:216–224. doi:10.1016/j.colsurfb.2014.02.034
   PubMed Web of Science ®Google Scholar
• Zhang YN, Poon W, Tavares AJ, McGilvray ID, Chan WCW. Nanoparticle–liver interactions: cellular uptake and hepatobiliary elimination. J Controlled Release. 2016;240:332–348. doi:10.1016/j.jconrel.2016.01.020
   PubMed Web of Science ®Google Scholar
• Nigam Y, Knight J. The lymphatic system 2: structure and function of the lymphoid organs. Nursing Times. 2020;116(11):44–48.
   Google Scholar
• Pivkin IV, Peng Z, Karniadakis GE, Buffet PA, Dao M, Suresh S. Biomechanics of red blood cells in human spleen and consequences for physiology and disease. Proc Natl Acad Sci. 2016;113(28):7804–7809. doi:10.1073/pnas.1606751113
   PubMed Web of Science ®Google Scholar
• Kopeć-Szlęzak J. Macrophages and their function in hematopoietic system. J Transfus Med. 2014;7(3):84–92.
   Google Scholar
• Demoy M, Andreux J, Weingarten C, Gouritin B, Guilloux V, Couvreur P. Spleen capture of nanoparticles: influence on animal species and surface characteristics. Pharm Res. 1999;16(1):37–41. doi:10.1023/A:1018858409737
   PubMed Web of Science ®Google Scholar
• Arami H, Khandhar AP, Tomitaka A, et al. In vivo multimodal magnetic particle imaging (MPI) with tailored magneto/optical contrast agents. Biomaterials. 2015;52:251–261. doi:10.1016/j.biomaterials.2015.02.040
   PubMed Web of Science ®Google Scholar
• Vu-Quang H, Yoo MK, Jeong HJ, et al. Targeted delivery of mannan-coated superparamagnetic iron oxide nanoparticles to antigen-presenting cells for magnetic resonance-based diagnosis of metastatic lymph nodes in vivo. Acta Biomater. 2011;7(11):3935–3945. doi:10.1016/j.actbio.2011.06.044
   PubMed Web of Science ®Google Scholar
• Harisinghani MG, Barentsz J, Hahn PF, et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med. 2003;348(25):2491–2499. doi:10.1056/NEJMoa022749
   PubMed Web of Science ®Google Scholar
• Corot C, Robert P, Idee J, Port M. Recent advances in iron oxide nanocrystal technology for medical imaging☆. Adv Drug Deliv Rev. 2006;58(14):1471–1504. doi:10.1016/j.addr.2006.09.013
   PubMed Web of Science ®Google Scholar
• Hauser PV, Chang HM, Yanagawa N, Nanotechnology HM. Nanomedicine, and the Kidney. Appl Sci. 2021;11(16):7187. doi:10.3390/app11167187
   Google Scholar
• Wook KJ, Cheong J, Cheong H, et al. Iron oxide-coated dextran nanoparticles with efficient renal clearance for musculoskeletal magnetic resonance imaging. ACS Appl Nano Mater. 2021;4(12):12943–12948. doi:10.1021/acsanm.1c03470
   Web of Science ®Google Scholar
• Bruners P, Braunschweig T, Hodenius M, et al. Thermoablation of malignant kidney tumors using magnetic nanoparticles: an in vivo feasibility study in a rabbit model. Cardiovasc Intervent Radiol. 2010;33(1):127–134. doi:10.1007/s00270-009-9583-x
   PubMed Web of Science ®Google Scholar
• Zuckerman JE, Choi CHJ, Han H, Davis ME. Polycation-siRNA nanoparticles can disassemble at the kidney glomerular basement membrane. Proc Natl Acad Sci. 2012;109(8):3137–3142. doi:10.1073/pnas.1200718109
   PubMed Web of Science ®Google Scholar
• Salimi M, Sarkar S, Fathi S, et al. Biodistribution, pharmacokinetics, and toxicity of dendrimer-coated iron oxide nanoparticles in BALB/c mice. Int J Nanomedicine. 2018;13:1483–1493. doi:10.2147/IJN.S157293
   PubMed Web of Science ®Google Scholar
• Zabel M. Histology: A Textbook for Students in Medicine and Dentistry. Edra Urban & Partner; 2021.
   Google Scholar
• Katsnelson B, Privalova LI, Kuzmin SV, et al. Some Peculiarities of Pulmonary Clearance Mechanisms in Rats after Intratracheal Instillation of Magnetite (Fe3 O4) Suspensions with Different Particle Sizes in the Nanometer and Micrometer Ranges: are We Defenseless against Nanoparticles? Int J Occup Environ Health. 2010;16(4):508–524. doi:10.1179/oeh.2010.16.4.508
   PubMed Web of Science ®Google Scholar
• Katsnelson B, Privalova L, Sutunkova M, et al. Some inferences from in vivo experiments with metal and metal oxide nanoparticles: the pulmonary phagocytosis response, subchronic systemic toxicity and genotoxicity, regulatory proposals, searching for bioprotectors (a self-overview). Int J Nanomedicine. 2015:3013. doi:10.2147/IJN.S80843
   PubMed Web of Science ®Google Scholar
• Edge D, Shortt CM, Gobbo OL, et al. Pharmacokinetics and bio-distribution of novel super paramagnetic iron oxide nanoparticles (SPIONs) in the anaesthetized pig. Clin Exp Pharmacol Physiol. 2016;43(3):319–326. doi:10.1111/1440-1681.12533
   PubMed Web of Science ®Google Scholar
• Kulkarni P, Rajadurai M, Sevilimedu A, et al. Magnetic nanoparticle formulation for targeted delivery of chemotherapeutic irinotecan to lungs. Drug Deliv Transl Res. 2018;8(5):1450–1459. doi:10.1007/s13346-018-0527-3
   PubMed Web of Science ®Google Scholar
• Haeger SM, Yang Y, Schmidt EP. Heparan Sulfate in the developing, healthy, and injured lung. Am J Respir Cell Mol Biol. 2016;55(1):5–11. doi:10.1165/rcmb.2016-0043TR
   PubMed Web of Science ®Google Scholar
• Rastogi A, Yadav K, Mishra A, et al. Early diagnosis of lung cancer using magnetic nanoparticles-integrated systems. Nanotechnol Rev. 2022;11(1):544–574. doi:10.1515/ntrev-2022-0032
   Web of Science ®Google Scholar
• Tan M, Reyes-Ortega F, Schneider-Futschik EK. Successes and challenges: inhaled treatment approaches using magnetic nanoparticles in cystic fibrosis. Magnetochemistry. 2020;6(2):25. doi:10.3390/magnetochemistry6020025
   Web of Science ®Google Scholar
• Chen M, Li X, Wang S, Yu L, Tang J, Zhou S. The role of cardiac macrophage and cytokines on ventricular arrhythmias. Front Physiol. 2020;11:1113. doi:10.3389/fphys.2020.01113
   PubMed Web of Science ®Google Scholar
• Lai RC, Arslan F, Lee MM, et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res. 2010;4(3):214–222. doi:10.1016/j.scr.2009.12.003
   PubMed Web of Science ®Google Scholar
• Bian S, Zhang L, Duan L, Wang X, Min Y, Yu H. Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model. J Mol Med. 2014;92(4):387–397. doi:10.1007/s00109-013-1110-5
   PubMed Web of Science ®Google Scholar
• Teng X, Chen L, Chen W, Yang J, Yang Z, Shen Z. Mesenchymal stem cell-derived exosomes improve the microenvironment of infarcted myocardium contributing to angiogenesis and anti-inflammation. Cell Physiol Biochem. 2015;37(6):2415–2424. doi:10.1159/000438594
   PubMed Web of Science ®Google Scholar
• Lee JR, Park BW, Kim J, et al. Nanovesicles derived from iron oxide nanoparticles–incorporated mesenchymal stem cells for cardiac repair. Sci Adv. 2020;6(18):eaaz0952. doi:10.1126/sciadv.aaz0952
   PubMed Web of Science ®Google Scholar
• Zheng B, von See MP, Yu E, et al. Quantitative magnetic particle imaging monitors the transplantation, biodistribution, and clearance of stem cells in vivo. Theranostics. 2016;6(3):291–301. doi:10.7150/thno.13728
   PubMed Web of Science ®Google Scholar
• Huang BR, Chen PY, Huang CY, et al. Bioavailability of magnetic nanoparticles to the brain. J Magn Magn Mater. 2009;321(10):1604–1609. doi:10.1016/j.jmmm.2009.02.095
   Web of Science ®Google Scholar
• Bagchi S, Lahooti B, Chhibber T, et al. In vitro models of central nervous system barriers for blood-brain barrier permeation studies. In: Morales JO, Gaillard PJ, editors. Nanomedicines for Brain Drug Delivery. Vol. 157. Neuromethods. Springer US; 2021:235–253. doi:10.1007/978-1-0716-0838-8_9
   Google Scholar
• Cecchelli R, Berezowski V, Lundquist S, et al. Modelling of the blood–brain barrier in drug discovery and development. Nat Rev Drug Discov. 2007;6(8):650–661. doi:10.1038/nrd2368
   PubMed Web of Science ®Google Scholar
• Cardoso FL, Brites D, Brito MA. Looking at the blood–brain barrier: molecular anatomy and possible investigation approaches. Brain Res Rev. 2010;64(2):328–363. doi:10.1016/j.brainresrev.2010.05.003
   PubMed Web of Science ®Google Scholar
• El Khoury J. The blood-brain barrier and pathogens: hadrian’s Wall or a Dardanian gate? Virulence. 2012;3(2):157–158. doi:10.4161/viru.19751
   PubMed Web of Science ®Google Scholar
• Kaur IP, Bhandari R, Bhandari S, Kakkar V. Potential of solid lipid nanoparticles in brain targeting. J Controlled Release. 2008;127(2):97–109. doi:10.1016/j.jconrel.2007.12.018
   PubMed Web of Science ®Google Scholar
• Kreuter J, Shamenkov D, Petrov V, et al. Apolipoprotein-mediated Transport of Nanoparticle-bound Drugs Across the Blood-Brain Barrier. J Drug Target. 2002;10(4):317–325. doi:10.1080/10611860290031877
   PubMed Web of Science ®Google Scholar
• Ulbrich K, Hekmatara T, Herbert E, Kreuter J. Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood–brain barrier (BBB). Eur J Pharm Biopharm. 2009;71(2):251–256. doi:10.1016/j.ejpb.2008.08.021
   PubMed Web of Science ®Google Scholar
• Yan F, Wang Y, He S, Ku S, Gu W, Ye L. Transferrin-conjugated, fluorescein-loaded magnetic nanoparticles for targeted delivery across the blood–brain barrier. J Mater Sci Mater Med. 2013;24(10):2371–2379. doi:10.1007/s10856-013-4993-3
   PubMed Web of Science ®Google Scholar
• Akhtari M, Bragin A, Cohen M, et al. Functionalized magnetonanoparticles for MRI diagnosis and localization in epilepsy. Epilepsia. 2008;49(8):1419–1430. doi:10.1111/j.1528-1167.2008.01615.x
   PubMed Web of Science ®Google Scholar
• Veiseh O, Sun C, Fang C, et al. Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier. Cancer Res. 2009;69(15):6200–6207. doi:10.1158/0008-5472.CAN-09-1157
   PubMed Web of Science ®Google Scholar
• Nadeem M, Ahmad M, Saeed MA, et al. Uptake and clearance analysis of Technetium 99m labelled iron oxide nanoparticles in a rabbit brain. IET Nanobiotechnol. 2015;9(3):136–141. doi:10.1049/iet-nbt.2014.0012
   PubMed Web of Science ®Google Scholar
• Raut SL, Kirthivasan B, Bommana MM, Squillante E, Sadoqi M. The formulation, characterization and in vivo evaluation of a magnetic carrier for brain delivery of NIR dye. Nanotechnology. 2010;21(39):395102. doi:10.1088/0957-4484/21/39/395102
   PubMed Web of Science ®Google Scholar
• Chen R, Romero G, Christiansen MG, Mohr A, Anikeeva P. Wireless magnetothermal deep brain stimulation. Science. 2015;347(6229):1477–1480. doi:10.1126/science.1261821
   PubMed Web of Science ®Google Scholar
• Wojtukiewicz MZ, Sierko E. The approach to antiangiogenic therapy in cancer patients. Onkol W Prakt Klin. 2009;5(A):A1–A14.
   Google Scholar
• Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol. 1995;146(5):1029–1039.
   PubMed Web of Science ®Google Scholar
• Jain RK, Stylianopoulos T. Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol. 2010;7(11):653–664. doi:10.1038/nrclinonc.2010.139
   PubMed Web of Science ®Google Scholar
• Briley-Saebo KC, Mani V, Hyafil F, Cornily JC, Fayad ZA. Fractionated feridex and positive contrast: in vivo MR imaging of atherosclerosis. Magn Reson Med. 2008;59(4):721–730. doi:10.1002/mrm.21541
   PubMed Web of Science ®Google Scholar
• Gupta AK, Wells S. Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies. IEEE Trans Nanobioscience. 2004;3(1):66–73. doi:10.1109/TNB.2003.820277
   PubMed Web of Science ®Google Scholar
• Plank C. Silence the target. Nat Nanotechnol. 2009;4(9):544–545. doi:10.1038/nnano.2009.251
   PubMed Web of Science ®Google Scholar
• Wu X, Yu G, Lindner D, Brady-Kalnay SM, Zhang Q, Lu ZR. Peptide targeted high-resolution molecular imaging of prostate cancer with MRI. Am J Nucl Med Mol Imaging. 2014;4(6):525–536.
   PubMedGoogle Scholar
• Jaiswal MK, Gogoi M, Dev Sarma H, Banerjee R, Bahadur D. Biocompatibility, biodistribution and efficacy of magnetic nanohydrogels in inhibiting growth of tumors in experimental mice models. Biomater Sci. 2014;2(3):370–380. doi:10.1039/C3BM60225G
   PubMed Web of Science ®Google Scholar
• Jie LY, Cai LL, Wang LJ, et al. Actively-targeted LTVSPWY peptide-modified magnetic nanoparticles for tumor imaging. Int J Nanomedicine. 2012;7:3981–3989. doi:10.2147/IJN.S33593
   PubMed Web of Science ®Google Scholar
• Krukemeyer MG, Krenn V, Jakobs M, Wagner W. Mitoxantrone-iron oxide biodistribution in blood, tumor, spleen, and liver—magnetic nanoparticles in cancer treatment. J Surg Res. 2012;175(1):35–43. doi:10.1016/j.jss.2011.01.060
   PubMed Web of Science ®Google Scholar
• Nowak-Jary J, Machnicka B. Pharmacokinetics of magnetic iron oxide nanoparticles for medical applications. J Nanobiotechnology. 2022;20(1):305. doi:10.1186/s12951-022-01510-w
   PubMed Web of Science ®Google Scholar
• Almeida JPM, Chen AL, Foster A, Drezek R. In vivo biodistribution of nanoparticles. Nanomed. 2011;6(5):815–835. doi:10.2217/nnm.11.79
   PubMed Web of Science ®Google Scholar
• Feng Q, Liu Y, Huang J, Chen K, Huang J, Xiao K. Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings. Sci Rep. 2018;8(1):2082. doi:10.1038/s41598-018-19628-z
   PubMedGoogle Scholar
• Ashizawa K. Nanosize Particle Analysis by Dynamic Light Scattering (DLS). YAKUGAKU ZASSHI. 2019;139(2):237–248. doi:10.1248/yakushi.18-00171-1
   PubMed Web of Science ®Google Scholar
• Alexis F, Pridgen E, Molnar LK, Farokhzad OC. Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles. Mol Pharm. 2008;5(4):505–515. doi:10.1021/mp800051m
   PubMed Web of Science ®Google Scholar
• Bourrinet P, Bengele HH, Bonnemain B, et al. Preclinical safety and pharmacokinetic profile of ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent. Invest Radiol. 2006;41(3):313–324. doi:10.1097/01.rli.0000197669.80475.dd
   PubMed Web of Science ®Google Scholar
• Reimer P, Tombach B. Hepatic MRI with SPIO: detection and characterization of focal liver lesions. Eur Radiol. 1998;8(7):1198–1204. doi:10.1007/s003300050535
   PubMed Web of Science ®Google Scholar
• Daldrup-Link HE. Ten Things You Might Not Know about Iron Oxide Nanoparticles. Radiology. 2017;284(3):616–629. doi:10.1148/radiol.2017162759
   PubMed Web of Science ®Google Scholar
• Harisinghani MG, Saksena MA, Hahn PF, et al. Ferumoxtran-10-enhanced MR lymphangiography: does contrast-enhanced imaging alone suffice for accurate lymph node characterization? Am J Roentgenol. 2006;186(1):144–148. doi:10.2214/AJR.04.1287
   PubMed Web of Science ®Google Scholar
• Weissleder R, Stark D, Engelstad B, et al. Superparamagnetic iron oxide: pharmacokinetics and toxicity. Am J Roentgenol. 1989;152(1):167–173. doi:10.2214/ajr.152.1.167
   PubMed Web of Science ®Google Scholar
• Chouly C, Pouliquen D, Lucet I, Jeune JJ, Jallet P. Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution. J Microencapsul. 1996;13(3):245–255. doi:10.3109/02652049609026013
   PubMed Web of Science ®Google Scholar
• Shao D, Meng LM, wei ZY, et al. The shape effect of magnetic mesoporous silica nanoparticles on endocytosis, biocompatibility and biodistribution. Acta Biomater. 2017;49:531–540. doi:10.1016/j.actbio.2016.11.007
   PubMed Web of Science ®Google Scholar
• Petros RA, DeSimone JM. Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov. 2010;9(8):615–627. doi:10.1038/nrd2591
   PubMed Web of Science ®Google Scholar
• Arnida J-AMM, Ray A, Peterson CM, Ghandehari H, Ghandehari H. Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages. Eur J Pharm Biopharm. 2011;77(3):417–423. doi:10.1016/j.ejpb.2010.11.010
   PubMed Web of Science ®Google Scholar
• Beola L, Grazú V, Fernández-Afonso Y, et al. Critical parameters to improve pancreatic cancer treatment using magnetic hyperthermia: field conditions, immune response, and particle biodistribution. ACS Appl Mater Interfaces. 2021;13(11):12982–12996. doi:10.1021/acsami.1c02338
   PubMed Web of Science ®Google Scholar
• Park J-H, von Maltzahn G, Zhang L, et al. Magnetic iron oxide nanoworms for tumor targeting and imaging. Adv Mater. 2008;20:1630–1635. doi:10.1002/adma.200800004
   PubMed Web of Science ®Google Scholar
• Kommareddy S, Amiji M. Biodistribution and pharmacokinetic analysis of long-circulating thiolated gelatin nanoparticles following systemic administration in breast cancer-bearing mice. J Pharm Sci. 2007;96:397–407. doi:10.1002/jps.20813
   PubMed Web of Science ®Google Scholar
• Papisov MI, Bogdanov A, Schaffer B, et al. Colloidal magnetic resonance contrast agents: effect of particle surface on biodistribution. J Magn Magn Mater. 1993;122(1–3):383–386. doi:10.1016/0304-8853(93)91115-N
   Web of Science ®Google Scholar
• Chertok B, Cole AJ, David AE, Yang VC. Comparison of electron spin resonance spectroscopy and inductively-coupled plasma optical emission spectroscopy for biodistribution analysis of iron-oxide nanoparticles. Mol Pharm. 2010;7(2):375–385. doi:10.1021/mp900161h
   PubMed Web of Science ®Google Scholar
• Yue ZG, Wei W, Lv PP, et al. Surface Charge Affects Cellular Uptake and Intracellular Trafficking of Chitosan-Based Nanoparticles. Biomacromolecules. 2011;12(7):2440–2446. doi:10.1021/bm101482r
   PubMed Web of Science ®Google Scholar
• Sun Z, Worden M, Wroczynskyj Y, et al. Magnetic field enhanced convective diffusion of iron oxide nanoparticles in an osmotically disrupted cell culture model of the blood–brain barrier. Int J Nanomedicine. 2014:3013. doi:10.2147/IJN.S62260
   PubMed Web of Science ®Google Scholar
• Sun Z, Worden M, Worden M, et al. Characterization of cellular uptake and toxicity of aminosilane-coated iron oxide nanoparticles with different charges in central nervous system-relevant cell culture models. Int J Nanomedicine. 2013:961. doi:10.2147/IJN.S39048
   PubMedGoogle Scholar
• On NH, Savant S, Toews M, Miller DW. Rapid and reversible enhancement of blood–brain barrier permeability using lysophosphatidic acid. J Cereb Blood Flow Metab. 2013;33(12):1944–1954. doi:10.1038/jcbfm.2013.154
   PubMed Web of Science ®Google Scholar
• Dutta D, Sundaram SK, Teeguarden JG, et al. Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials. Toxicol Sci. 2007;100(1):303–315. doi:10.1093/toxsci/kfm217
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev. 2001;53(2):283–318.
   PubMed Web of Science ®Google Scholar
• Nagayama S, ichi OK, Fukuoka Y, Higaki K, Kimura T. Time-dependent changes in opsonin amount associated on nanoparticles alter their hepatic uptake characteristics. Int J Pharm. 2007;342(1–2):215–221. doi:10.1016/j.ijpharm.2007.04.036
   PubMed Web of Science ®Google Scholar
• Camner P, Lundborg M, Låstbom L, Gerde P, Gross N, Jarstrand C. Experimental and calculated parameters on particle phagocytosis by alveolar macrophages. J Appl Physiol. 2002;92(6):2608–2616. doi:10.1152/japplphysiol.01067.2001
   PubMed Web of Science ®Google Scholar
• Leroux JC, De Jaeghere F, Anner B, Doelker E, Gurny R. An investigation on the role of plasma and serum opsonins on the evternalization of biodegradable poly(D,L-lactic acid) nanoparticles by human monocytes. Life Sci. 1995;57(7):695–703. doi:10.1016/0024-3205(95)00321-V
   PubMed Web of Science ®Google Scholar
• Chen H, Wang L, Yeh J, et al. Reducing non-specific binding and uptake of nanoparticles and improving cell targeting with an antifouling PEO-b-PγMPS copolymer coating. Biomaterials. 2010;31(20):5397–5407. doi:10.1016/j.biomaterials.2010.03.036
   PubMed Web of Science ®Google Scholar
• Cole AJ, David AE, Wang J, Galbán CJ, Hill HL, Yang VC. Polyethylene glycol modified, cross-linked starch-coated iron oxide nanoparticles for enhanced magnetic tumor targeting. Biomaterials. 2011;32(8):2183–2193. doi:10.1016/j.biomaterials.2010.11.040
   PubMed Web of Science ®Google Scholar
• Larsen EKU, Nielsen T, Wittenborn T, et al. Size-Dependent Accumulation of PEGylated Silane-Coated Magnetic Iron Oxide Nanoparticles in Murine Tumors. ACS Nano. 2009;3(7):1947–1951. doi:10.1021/nn900330m
   PubMed Web of Science ®Google Scholar
• Sun C, Du K, Fang C, et al. PEG-mediated synthesis of highly dispersive multifunctional superparamagnetic nanoparticles: their physicochemical properties and function in vivo. ACS Nano. 2010;4(4):2402–2410. doi:10.1021/nn100190v
   PubMed Web of Science ®Google Scholar
• Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev. 2009;61(6):428–437. doi:10.1016/j.addr.2009.03.009
   PubMed Web of Science ®Google Scholar
• Liu S, Chiu-Lam A, Rivera-Rodriguez A, et al. Long circulating tracer tailored for magnetic particle imaging. Nanotheranostics. 2021;5(3):348–361. doi:10.7150/ntno.58548
   PubMedGoogle Scholar
• Jain TK, Morales MA, Sahoo SK, Leslie-Pelecky DL, Labhasetwar V. Iron oxide nanoparticles for sustained delivery of anticancer agents. Mol Pharm. 2005;2(3):194–205. doi:10.1021/mp0500014
   PubMed Web of Science ®Google Scholar
• Briley-Saebo K, Bjornerud A, Grant D, Ahlstrom H, Berg T, Kindberg GM. Hepatic cellular distribution and degradation of iron oxide nanoparticles following single intravenous injection in rats: implications for magnetic resonance imaging. Cell Tissue Res. 2004;316(3):315–323. doi:10.1007/s00441-004-0884-8
   PubMed Web of Science ®Google Scholar
• Ikeda H, Ishii A, Sano K, et al. Activatable fluorescence imaging of macrophages in atherosclerotic plaques using iron oxide nanoparticles conjugated with indocyanine green. Atherosclerosis. 2018;275:1–10. doi:10.1016/j.atherosclerosis.2018.05.028
   PubMed Web of Science ®Google Scholar
• Wang H, Mu Q, Revia R, et al. Iron oxide-carbon core-shell nanoparticles for dual-modal imaging-guided photothermal therapy. J Controlled Release. 2018;289:70–78. doi:10.1016/j.jconrel.2018.09.022
   PubMed Web of Science ®Google Scholar
• Holig P, Bach M, Volkel T, et al. Novel RGD lipopeptides for the targeting of liposomes to integrin-expressing endothelial and melanoma cells. Protein Eng Des Sel. 2004;17(5):433–441. doi:10.1093/protein/gzh055
   PubMed Web of Science ®Google Scholar
• Corti A, Curnis F, Arap W, Pasqualini R. The neovasculature homing motif NGR: more than meets the eye. Blood. 2008;112(7):2628–2635. doi:10.1182/blood-2008-04-150862
   PubMed Web of Science ®Google Scholar
• Wu T, Ding X, Su B, Soodeen-Lalloo AK, Zhang L, Shi JY. Magnetic resonance imaging of tumor angiogenesis using dual-targeting RGD10–NGR9 ultrasmall superparamagnetic iron oxide nanoparticles. Clin Transl Oncol. 2018;20(5):599–606. doi:10.1007/s12094-017-1753-8
   PubMed Web of Science ®Google Scholar
• Curnis F, Sacchi A, Gasparri A, et al. Isoaspartate-Glycine-Arginine: a New Tumor Vasculature–Targeting Motif. Cancer Res. 2008;68(17):7073–7082. doi:10.1158/0008-5472.CAN-08-1272
   PubMed Web of Science ®Google Scholar
• Zhang C, Jugold M, Woenne EC, et al. Specific Targeting of Tumor Angiogenesis by RGD-Conjugated Ultrasmall Superparamagnetic Iron Oxide Particles Using a Clinical 1.5-T Magnetic Resonance Scanner. Cancer Res. 2007;67(4):1555–1562. doi:10.1158/0008-5472.CAN-06-1668
   PubMed Web of Science ®Google Scholar
• Oostendorp M, Douma K, Hackeng TM, et al. Quantitative molecular magnetic resonance imaging of tumor angiogenesis using cNGR-labeled paramagnetic quantum dots. Cancer Res. 2008;68(18):7676–7683. doi:10.1158/0008-5472.CAN-08-0689
   PubMed Web of Science ®Google Scholar
• Kojima C, Turkbey B, Ogawa M, et al. Dendrimer-based MRI contrast agents: the effects of PEGylation on relaxivity and pharmacokinetics. Nanomedicine Nanotechnol Biol Med. 2011;7(6):1001–1008. doi:10.1016/j.nano.2011.03.007
   PubMed Web of Science ®Google Scholar
• Longmire M, Choyke P, Kobayashi H. Dendrimer-based contrast agents for molecular imaging. Curr Top Med Chem. 2008;8(14):1180–1186. doi:10.2174/156802608785849021
   PubMed Web of Science ®Google Scholar
• Al Faraj A, Shaik AP, Shaik AS. Effect of surface coating on the biocompatibility and in vivo MRI detection of iron oxide nanoparticles after intrapulmonary administration. Nanotoxicology. 2015;9(7):825–834. doi:10.3109/17435390.2014.980450
   PubMed Web of Science ®Google Scholar
• Yang P, Xu H, Zhang Z, Yang L, Kuang H, Aguilar ZP. Surface modification affect the biodistribution and toxicity characteristics of iron oxide magnetic nanoparticles in rats. IET Nanobiotechnol. 2018;12(5):562–568. doi:10.1049/iet-nbt.2017.0152
   PubMed Web of Science ®Google Scholar
• de Oliveira PN, Moussa A, Milhau N, et al. In situ synthesis of Fe3O4 nanoparticles coated by chito-oligosaccharides: physico-chemical characterizations and cytotoxicity evaluation for biomedical applications. Nanotechnology. 2020;31(17):175602. doi:10.1088/1361-6528/ab68f9
   PubMed Web of Science ®Google Scholar
• Demin AM, Vakhrushev AV, Mekhaev AV, Uimin MA, Krasnov VP. Modification of Fe3O4 magnetic nanoparticles with a GRGD peptide. Russ Chem Bull. 2021;70(3):449–456. doi:10.1007/s11172-021-3107-5
   Web of Science ®Google Scholar
• Yang X, Hong H, Grailer JJ, et al. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging. Biomaterials. 2011;32(17):4151–4160. doi:10.1016/j.biomaterials.2011.02.006
   PubMed Web of Science ®Google Scholar
• Kang T, Jiang M, Jiang D, et al. Enhancing glioblastoma-specific penetration by functionalization of nanoparticles with an iron-mimic peptide targeting transferrin/transferrin receptor complex. Mol Pharm. 2015;12(8):2947–2961. doi:10.1021/acs.molpharmaceut.5b00222
   PubMedGoogle Scholar
• Jiang W, Xie H, Ghoorah D, et al. Conjugation of Functionalized SPIONs with Transferrin for Targeting and Imaging Brain Glial Tumors in Rat Model. PLoS One. 2012;7(5):e37376. doi:10.1371/journal.pone.0037376
   PubMed Web of Science ®Google Scholar
• Wang X, Chang Y, Zhang D, Tian B, Yang Y, Wei F. Transferrin-conjugated drug/dye-co-encapsulated magnetic nanocarriers for active-targeting fluorescent/magnetic resonance imaging and anti-tumor effects in human brain tumor cells. RSC Adv. 2016;6(107):105661–105675. doi:10.1039/C6RA20903C
   Web of Science ®Google Scholar
• Ghadiri M, Vasheghani-Farahani E, Atyabi F, Kobarfard F, Mohamadyar-Toupkanlou F, Hosseinkhani H. Transferrin-conjugated magnetic dextran-spermine nanoparticles for targeted drug transport across blood-brain barrier. J Biomed Mater Res A. 2017;105(10):2851–2864. doi:10.1002/jbm.a.36145
   PubMed Web of Science ®Google Scholar
• Tomitaka A, Arami H, Gandhi S, Krishnan KM. Lactoferrin conjugated iron oxide nanoparticles for targeting brain glioma cells in magnetic particle imaging. Nanoscale. 2015;7(40):16890–16898. doi:10.1039/C5NR02831K
   PubMed Web of Science ®Google Scholar
• Gupta AK, Berry C, Gupta M, Curtis A. Receptor-mediated targeting of magnetic nanoparticles using insulin as a surface ligand to prevent endocytosis. IEEE Trans Nanobioscience. 2003;2(4):255–261. doi:10.1109/TNB.2003.820279
   PubMed Web of Science ®Google Scholar
• Kou G, Wang S, Cheng C, et al. Development of SM5-1-conjugated ultrasmall superparamagnetic iron oxide nanoparticles for hepatoma detection. Biochem Biophys Res Commun. 2008;374(2):192–197. doi:10.1016/j.bbrc.2008.06.126
   PubMed Web of Science ®Google Scholar
• Thomsen LB, Thomsen MS, Moos T. Targeted drug delivery to the brain using magnetic nanoparticles. Ther Deliv. 2015;6(10):1145–1155. doi:10.4155/tde.15.56
   PubMedGoogle Scholar
• Thomsen LB, Linemann T, Birkelund S, Tarp GA, Moos T. Evaluation of targeted delivery to the brain using magnetic immunoliposomes and magnetic force. Materials. 2019;12(21):3576. doi:10.3390/ma12213576
   PubMed Web of Science ®Google Scholar
• Wathoni N, Puluhulawa LE, Joni IM, et al. Monoclonal antibody as a targeting mediator for nanoparticle targeted delivery system for lung cancer. Drug Deliv. 2022;29(1):2959–2970. doi:10.1080/10717544.2022.2120566
   PubMed Web of Science ®Google Scholar
• Boutry S, Laurent S, Elst LV, Muller RN. Specific E-selectin targeting with a superparamagnetic MRI contrast agent. Contrast Media Mol Imaging. 2006;1(1):15–22. doi:10.1002/cmmi.87
   PubMed Web of Science ®Google Scholar
• Akal ZÜ, Alpsoy L, Baykal A. Superparamagnetic iron oxide conjugated with folic acid and carboxylated quercetin for chemotherapy applications. Ceram Int. 2016;42(7):9065–9072. doi:10.1016/j.ceramint.2016.02.166
   Web of Science ®Google Scholar
• Li L, Gao F, Jiang W, et al. Folic acid-conjugated superparamagnetic iron oxide nanoparticles for tumor-targeting MR imaging. Drug Deliv. 2015:1–8. doi:10.3109/10717544.2015.1006404
   Web of Science ®Google Scholar
• Mohammed L, Gomaa HG, Ragab D, Zhu J. Magnetic nanoparticles for environmental and biomedical applications: a review. Particuology. 2017;30:1–14. doi:10.1016/j.partic.2016.06.001
   Web of Science ®Google Scholar
• Zheng S, Han J, Jin Z, et al. Dual-Tumor-Targeted Multifunctional Magnetic Hyaluronic Acid Micelles for Enhanced MR Imaging and Combined Photothermal -Chemotherapy. Colloids Surf B. 2018;164:424–435. doi:10.1016/j.colsurfb.2018.02.005
   PubMed Web of Science ®Google Scholar
• Luo Y, Gao C, Chen W, Zhou K, Xu M. Molecular Magnetic Resonance Imaging with Contrast Agents for Assessment of Inflammatory Bowel Disease: a Systematic Review. Contrast Media Mol Imaging. 2020;2020:4764985. doi:10.1155/2020/4764985
   PubMed Web of Science ®Google Scholar
• Huang J, Shu Q, Wang L, Wu H, Wang AY, Mao H. Layer-by-layer assembled milk protein coated magnetic nanoparticle enabled oral drug delivery with high stability in stomach and enzyme-responsive release in small intestine. Biomaterials. 2015;39:105–113. doi:10.1016/j.biomaterials.2014.10.059
   PubMed Web of Science ®Google Scholar
• Mohd Tamsir N, Mohd Esa N, Shafie NH, Hussein MZ, Hamzah H, Abdullah MA. The acute effects of oral administration of phytic acid-chitosan-magnetic iron oxide nanoparticles in mice. Int J Mol Sci. 2019;20(17):4114. doi:10.3390/ijms20174114
   PubMed Web of Science ®Google Scholar
• Smith CA, Simpson CA, Kim G, Carter CJ, Feldheim DL. Gastrointestinal Bioavailability of 2.0 nm Diameter Gold Nanoparticles. ACS Nano. 2013;7(5):3991–3996. doi:10.1021/nn305930e
   PubMed Web of Science ®Google Scholar
• Butterworth MD, Illum L, Davis SS. Preparation of ultrafine silica- and PEG-coated magnetite particles. Colloids Surf Physicochem Eng Asp. 2001;179(1):93–102. doi:10.1016/S0927-7757(00)00633-6
   Web of Science ®Google Scholar
• Arruebo M, Fernández-Pacheco R, Ibarra MR, Santamaría J. Magnetic nanoparticles for drug delivery. Nano Today. 2007;2(3):22–32. doi:10.1016/S1748-0132(07)70084-1
   Web of Science ®Google Scholar
• Bailey MM, Berkland CJ. Nanoparticle formulations in pulmonary drug delivery. Med Res Rev. 2009;29(1):196–212. doi:10.1002/med.20140
   PubMed Web of Science ®Google Scholar
• Reid DW, Anderson GJ, Lamont IL. Role of lung iron in determining the bacterial and host struggle in cystic fibrosis. Am J Physiol-Lung Cell Mol Physiol. 2009;297(5):L795–L802. doi:10.1152/ajplung.00132.2009
   PubMed Web of Science ®Google Scholar
• Heilig EA, Thompson KJ, Molina RM, Ivanov AR, Brain JD, Wessling-Resnick M. Manganese and iron transport across pulmonary epithelium. Am J Physiol-Lung Cell Mol Physiol. 2006;290(6):L1247–L1259. doi:10.1152/ajplung.00450.2005
   PubMed Web of Science ®Google Scholar
• Alexiou C, Schmidt A, Klein R, Hulin P, Bergemann C, Arnold W. Magnetic drug targeting: biodistribution and dependency on magnetic field strength. J Magn Magn Mater. 2002;252:363–366. doi:10.1016/S0304-8853(02)00605-4
   Web of Science ®Google Scholar
• Wu T, Hua MY, ping CJ, et al. Effects of external magnetic field on biodistribution of nanoparticles: a histological study. J Magn Magn Mater. 2007;311(1):372–375. doi:10.1016/j.jmmm.2006.10.1202
   Web of Science ®Google Scholar
• Gutierrez L, Mejias R, Lazaro FJ, Serna CJ, Barber DF, Morales MP. Effect of anesthesia on magnetic nanoparticle biodistribution after intravenous injection. IEEE Trans Magn. 2013;49(1):398–401. doi:10.1109/TMAG.2012.2221162
   Web of Science ®Google Scholar
• Du B, Yu M, Zheng J. Transport and interactions of nanoparticles in the kidneys. Nat Rev Mater. 2018;3(10):358–374. doi:10.1038/s41578-018-0038-3
   Web of Science ®Google Scholar
• Hall JE. Guyton and Hall Textbook of Medical Physiology. 14th ed. Elsevier; 2020.
   Google Scholar
• Crichton RR, Charloteaux-Wauters M. Iron transport and storage. Eur J Biochem. 1987;164(3):485–506. doi:10.1111/j.1432-1033.1987.tb11155.x
   PubMedGoogle Scholar
• Alphandéry E, Faure S, Seksek O, Guyot F, Chebbi I. Chains of Magnetosomes Extracted from AMB-1 Magnetotactic Bacteria for Application in Alternative Magnetic Field Cancer Therapy. ACS Nano. 2011;5(8):6279–6296. doi:10.1021/nn201290k
   PubMed Web of Science ®Google Scholar
• Arbab AS, Wilson LB, Ashari P, Jordan EK, Lewis BK, Frank JA. A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging. NMR Biomed. 2005;18(6):383–389. doi:10.1002/nbm.970
   PubMed Web of Science ®Google Scholar
• Wahajuddin A. Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers. Int J Nanomedicine. 2012;3445. doi:10.2147/IJN.S30320
   PubMed Web of Science ®Google Scholar
• Lartigue L, Alloyeau D, Kolosnjaj-Tabi J, et al. Biodegradation of iron oxide nanocubes: high-resolution in situ monitoring. ACS Nano. 2013;7(5):3939–3952. doi:10.1021/nn305719y
   PubMed Web of Science ®Google Scholar
• Lunov O, Syrovets T, Röcker C, et al. Lysosomal degradation of the carboxydextran shell of coated superparamagnetic iron oxide nanoparticles and the fate of professional phagocytes. Biomaterials. 2010;31(34):9015–9022. doi:10.1016/j.biomaterials.2010.08.003
   PubMed Web of Science ®Google Scholar
• Arami H, Krishnan KM. Intracellular performance of tailored nanoparticle tracers in magnetic particle imaging. J Appl Phys. 2014;115(17):17B306. doi:10.1063/1.4867756
   PubMed Web of Science ®Google Scholar
• Okon E, Pouliquen D, Okon P, et al. Biodegradation of magnetite dextran nanoparticles in the rat. A histologic and biophysical study. Lab Investig J Tech Methods Pathol. 1994;71(6):895–903.
   PubMed Web of Science ®Google Scholar
• Zhang X, Liu C, Yuan Y, Shan X, Sheng Y, Xu F. Reduction and suppression of methemoglobin loaded in the polymeric nanoparticles intended for blood substitutes. J Biomed Mater Res B Appl Biomater. 2008;87B(2):354–363. doi:10.1002/jbm.b.31110
   Web of Science ®Google Scholar
• Jensen JH, Tang H, Tosti CL, et al. Separate MRI quantification of dispersed (ferritin-like) and aggregated (hemosiderin-like) storage iron. Magn Reson Med. 2010;63(5):1201–1209. doi:10.1002/mrm.22273
   PubMed Web of Science ®Google Scholar
• Nosrati H, Tarantash M, Bochani S, et al. Glutathione (GSH) Peptide Conjugated Magnetic Nanoparticles As Blood–Brain Barrier Shuttle for MRI-Monitored Brain Delivery of Paclitaxel. ACS Biomater Sci Eng. 2019;5(4):1677–1685. doi:10.1021/acsbiomaterials.8b01420
   Web of Science ®Google Scholar
• Gu X, Song Q, Zhang Q, et al. Clearance of two organic nanoparticles from the brain via the paravascular pathway. J Controlled Release. 2020;322:31–41. doi:10.1016/j.jconrel.2020.03.009
   PubMed Web of Science ®Google Scholar
• Arms L, Smith DW, Flynn J, et al. Advantages and limitations of current techniques for analyzing the biodistribution of nanoparticles. Front Pharmacol. 2018;9:802. doi:10.3389/fphar.2018.00802
   PubMed Web of Science ®Google Scholar
• Pham B, Colvin E, Pham N, et al. Biodistribution and clearance of stable superparamagnetic maghemite iron oxide nanoparticles in mice following intraperitoneal administration. Int J Mol Sci. 2018;19(1):205. doi:10.3390/ijms19010205
   PubMed Web of Science ®Google Scholar
• Robson AL, Dastoor PC, Flynn J, et al. Advantages and limitations of current imaging techniques for characterizing liposome morphology. Front Pharmacol. 2018;9:80. doi:10.3389/fphar.2018.00080
   PubMed Web of Science ®Google Scholar
• Shigematsu A, Motoji N, Hatori A, Satoh T. Progressive application of autoradiography in pharmacokinetic and metabolic studies for the development of new drugs. Regul Toxicol Pharmacol. 1995;22(2):122–142. doi:10.1006/rtph.1995.1078
   PubMed Web of Science ®Google Scholar
• Mayhew TM, Mühlfeld C, Vanhecke D, Ochs M. A review of recent methods for efficiently quantifying immunogold and other nanoparticles using TEM sections through cells, tissues and organs. Ann Anat - Anat Anz. 2009;191(2):153–170. doi:10.1016/j.aanat.2008.11.001
   PubMed Web of Science ®Google Scholar
• García-Negrete CA, Jiménez de Haro MC, Blasco J, Soto M, Fernández A. STEM-in-SEM high resolution imaging of gold nanoparticles and bivalve tissues in bioaccumulation experiments. Analyst. 2015;140(9):3082–3089. doi:10.1039/C4AN01643B
   PubMed Web of Science ®Google Scholar
• Mühlfeld C, Rothen-Rutishauser B, Vanhecke D, Blank F, Gehr P, Ochs M. Visualization and quantitative analysis of nanoparticles in the respiratory tract by transmission electron microscopy. Part Fibre Toxicol. 2007;4(1):11. doi:10.1186/1743-8977-4-11
   PubMedGoogle Scholar
• Jong WHD, Burger MC, Verheijen MA, Geertsma RE. Detection of the presence of gold nanoparticles in organs by transmission electron microscopy. Materials. 2010;3(9):4681–4694. doi:10.3390/ma3094681
   PubMed Web of Science ®Google Scholar
• Kempen PJ, Thakor AS, Zavaleta C, Gambhir SS, Sinclair R. A scanning transmission electron microscopy approach to analyzing large volumes of tissue to detect nanoparticles. Microsc Microanal. 2013;19(5):1290–1297. doi:10.1017/S143192761300192X
   PubMed Web of Science ®Google Scholar
• Paddock SW. Principles and practices of laser scanning confocal microscopy. Mol Biotechnol. 2000;16(2):127–150. doi:10.1385/MB:16:2:127
   PubMed Web of Science ®Google Scholar
• Huang Y, Mao K, Zhang B, Zhao Y. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics. Mater Sci Eng C. 2017;70:763–771. doi:10.1016/j.msec.2016.09.052
   PubMed Web of Science ®Google Scholar
• Strijkers GJ, Mulder WJ, van Tilborg GA, Nicolay K. MRI contrast agents: current status and future perspectives. Anticancer Agents Med Chem. 2007;7(3):291–305. doi:10.2174/187152007780618135
   PubMed Web of Science ®Google Scholar
• Kamaly N, Miller AD. Paramagnetic liposome nanoparticles for cellular and tumour imaging. Int J Mol Sci. 2010;11(4):1759–1776. doi:10.3390/ijms11041759
   PubMed Web of Science ®Google Scholar
• Kim BH, Lee N, Kim H, et al. Large-Scale Synthesis of Uniform and Extremely Small-Sized Iron Oxide Nanoparticles for High-Resolution T1 Magnetic Resonance Imaging Contrast Agents. J Am Chem Soc. 2011;133(32):12624–12631. doi:10.1021/ja203340u
   PubMed Web of Science ®Google Scholar
• Pablico-Lansigan MH, Situ SF, Samia ACS. Magnetic particle imaging: advancements and perspectives for real-time in vivo monitoring and image-guided therapy. Nanoscale. 2013;5(10):4040. doi:10.1039/c3nr00544e
   PubMed Web of Science ®Google Scholar
• Ferguson RM, Minard KR, Krishnan KM. Optimization of nanoparticle core size for magnetic particle imaging. J Magn Magn Mater. 2009;321(10):1548–1551. doi:10.1016/j.jmmm.2009.02.083
   PubMed Web of Science ®Google Scholar
• Gleich B, Weizenecker J. Tomographic imaging using the nonlinear response of magnetic particles. Nature. 2005;435(7046):1214–1217. doi:10.1038/nature03808
   PubMed Web of Science ®Google Scholar
• Gleich B, Weizenecker J, Borgert J. Experimental results on fast 2D-encoded magnetic particle imaging. Phys Med Biol. 2008;53(6):N81–N84. doi:10.1088/0031-9155/53/6/N01
   PubMed Web of Science ®Google Scholar
• Madru R, Kjellman P, Olsson F, et al. 99m Tc-Labeled Superparamagnetic Iron Oxide Nanoparticles for Multimodality SPECT/MRI of Sentinel Lymph Nodes. J Nucl Med. 2012;53(3):459–463. doi:10.2967/jnumed.111.092437
   PubMed Web of Science ®Google Scholar
• Pimlott SL, Sutherland A. Molecular tracers for the PET and SPECT imaging of disease. Chem Soc Rev. 2011;40(1):149–162. doi:10.1039/B922628C
   PubMed Web of Science ®Google Scholar
• Van Audenhaege K, Van Holen R, Vandenberghe S, Vanhove C, Metzler SD, Moore SC. Review of SPECT collimator selection, optimization, and fabrication for clinical and preclinical imaging: review of SPECT collimator selection, optimization, and fabrication. Med Phys. 2015;42(8):4796–4813. doi:10.1118/1.4927061
   PubMed Web of Science ®Google Scholar
• Hong Y, Zhu H, Hu J, et al. Synthesis and radiolabeling of 111In-core-cross linked polymeric micelle-octreotide for near-infrared fluoroscopy and single photon emission computed tomography imaging. Bioorg Med Chem Lett. 2014;24(12):2781–2785. doi:10.1016/j.bmcl.2014.03.050
   PubMed Web of Science ®Google Scholar
• Wiekhorst F, Steinhoff U, Eberbeck D, Trahms L. Magnetorelaxometry assisting biomedical applications of magnetic nanoparticles. Pharm Res. 2012;29(5):1189–1202. doi:10.1007/s11095-011-0630-3
   PubMed Web of Science ®Google Scholar
• Dames P, Gleich B, Flemmer A, et al. Targeted delivery of magnetic aerosol droplets to the lung. Nat Nanotechnol. 2007;2(8):495–499. doi:10.1038/nnano.2007.217
   PubMed Web of Science ®Google Scholar
• Johnson C, Adolphi NL, Butler KL, et al. Magnetic relaxometry with an atomic magnetometer and SQUID sensors on targeted cancer cells. J Magn Magn Mater. 2012;324(17):2613–2619. doi:10.1016/j.jmmm.2012.03.015
   PubMed Web of Science ®Google Scholar
• Kötitz R, Weitschies W, Trahms L, Semmler W. Investigation of Brownian and Néel relaxation in magnetic fluids. J Magn Magn Mater. 1999;201(1–3):102–104. doi:10.1016/S0304-8853(99)00065-7
   Google Scholar
• Roessler MM, Salvadori E. Principles and applications of EPR spectroscopy in the chemical sciences. Chem Soc Rev. 2018;47(8):2534–2553. doi:10.1039/C6CS00565A
   PubMed Web of Science ®Google Scholar
• Gamarra LF, Pontuschka WM, Amaro E, et al. Kinetics of elimination and distribution in blood and liver of biocompatible ferrofluids based on Fe3O4 nanoparticles: an EPR and XRF study. Mater Sci Eng C. 2008;28(4):519–525. doi:10.1016/j.msec.2007.06.005
   Google Scholar
• Ślawska-Waniewska A, Mosiniewicz-Szablewska E, Nedelko N, Gałązka-Friedman J, Friedman A. Magnetic studies of iron-entities in human tissues. J Magn Magn Mater. 2004;272-276:2417–2419. doi:10.1016/j.jmmm.2003.12.843
   Web of Science ®Google Scholar
• Danhier P, Gallez B. Electron paramagnetic resonance: a powerful tool to support magnetic resonance imaging research: EPR AS A TOOL TO SUPPORT MRI RESEARCH. Contrast Media Mol Imaging. 2015;10(4):266–281. doi:10.1002/cmmi.1630
   PubMed Web of Science ®Google Scholar
• Gobbo OL, Wetterling F, Vaes P, et al. Biodistribution and pharmacokinetic studies of SPION using particle electron paramagnetic resonance, MRI and ICP-MS. Nanomed. 2015;10(11):1751–1760. doi:10.2217/nnm.15.22
   PubMed Web of Science ®Google Scholar
• Zettner A. Principles and Applications of Atomic Absorption Spectroscopy. Adv Clin Chem. 1964;7:1–62. doi:10.1016/S0065-2423(08)60372-8
   PubMed Web of Science ®Google Scholar
• Van Loon JC. Analytical Atomic Absorption Spectroscopy: Selected Methods. Academic Press; 1980.
   Google Scholar
• Szczepaniak W. Metody instrumentalne w analizie chemicznej. Naukowe PWN; 2002.
   Google Scholar
• Welz B. Atomic Absorption Spectrometry. 3rd ed. Wiley-VCH; 1999.
   Google Scholar
• Ficko BW, Nadar PM, Hoopes PJ, Diamond SG. Development of a magnetic nanoparticle susceptibility magnitude imaging array. Phys Med Biol. 2014;59(4):1047–1071. doi:10.1088/0031-9155/59/4/1047
   PubMed Web of Science ®Google Scholar
• Park K, Harrah T, Goldberg EB, Guertin RP, Sonkusale S. Multiplexed sensing based on Brownian relaxation of magnetic nanoparticles using a compact AC susceptometer. Nanotechnology. 2011;22(8):085501. doi:10.1088/0957-4484/22/8/085501
   PubMed Web of Science ®Google Scholar
• Narayanasamy KK, Cruz-Acuña M, Rinaldi C, Everett J, Dobson J, Telling ND. Alternating current (AC) susceptibility as a particle-focused probe of coating and clustering behaviour in magnetic nanoparticle suspensions. J Colloid Interface Sci. 2018;532:536–545. doi:10.1016/j.jcis.2018.08.014
   PubMed Web of Science ®Google Scholar
• Gutiérrez L, Romero S, da Silva GB, et al. Degradation of magnetic nanoparticles mimicking lysosomal conditions followed by AC susceptibility. Biomed Eng Biomed Tech. 2015;60(5). doi:10.1515/bmt-2015-0043
   PubMed Web of Science ®Google Scholar
• Costo R, Heinke D, Grüttner C, et al. Improving the reliability of the iron concentration quantification for iron oxide nanoparticle suspensions: a two-institutions study. Anal Bioanal Chem. 2019;411(9):1895–1903. doi:10.1007/s00216-018-1463-2
   PubMed Web of Science ®Google Scholar
• Albanese A, Tsoi KM, Chan WCW. Simultaneous quantification of cells and nanomaterials by inductive-coupled plasma techniques. J Lab Autom. 2013;18(1):99–104. doi:10.1177/2211068212457039
   PubMedGoogle Scholar
• Kruszewska J, Sikorski J, Samsonowicz-Górski J, Matczuk M. A CE-ICP-MS/MS method for the determination of superparamagnetic iron oxide nanoparticles under simulated physiological conditions. Anal Bioanal Chem. 2020;412(29):8145–8153. doi:10.1007/s00216-020-02948-3
   PubMed Web of Science ®Google Scholar
• Kuznetsova OV, Mokhodoeva OB, Maksimova VV, et al. High-resolution ICP-MS approach for characterization of magnetic nanoparticles for biomedical applications. J Pharm Biomed Anal. 2020;189:113479. doi:10.1016/j.jpba.2020.113479
   PubMed Web of Science ®Google Scholar